Neulasta and Dexamethasone drug interactions for women aged 50-59 (a phase IV clinical study of FDA data)

Summary:

Drug interactions are found for women aged 50-59 who take Neulasta (pegfilgrastim) and Dexamethasone (dexamethasone) together. We list drug interactions by the duration when the drugs are taken. This phase IV study is created by eHealthMe based on reports of 403 people from the FDA, and is updated regularly.



On Mar, 07, 2026

403 women aged 50-59 who take Neulasta, Dexamethasone and have drug interactions are studied.


What is Neulasta?

Neulasta has active ingredients of pegfilgrastim. It is often used in agranulocytosis. eHealthMe is studying from 92,286 Neulasta users. Check the latest studies of Neulasta.

What is Dexamethasone?

Dexamethasone has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 161,927 Dexamethasone users. Check the latest studies of Dexamethasone.

Number of reports submitted per year:

Neulasta and Dexamethasone drug interactions in women aged 50-59.

Most common drug interactions over time *:

< 1 month:

  1. Pyrexia (fever)
  2. Platelet count decreased
  3. Chest pain
  4. Anaemia (lack of blood)
  5. Parotitis (inflammation of a parotid gland)
  6. Colitis (inflammation of colon)
  7. Fatigue (feeling of tiredness)
  8. Nausea (feeling of having an urge to vomit)
  9. Decreased appetite
  10. Liver disorder (liver diseases)

1 - 6 months:

  1. Encephalopathy (functioning of the brain is affected by some agent or condition)
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Lymphoedema (localized fluid retention and tissue swelling)
  4. Myalgia (muscle pain)
  5. Oral pain
  6. Respiratory failure (inadequate gas exchange by the respiratory system)
  7. Staphylococcal infection (an infection with staphylococcus bacteria)
  8. Thrombocytopenia (decrease of platelets in blood)
  9. Tooth infection
  10. Troponin t increased

6 - 12 months:

  1. Alopecia (absence of hair from areas of the body)
  2. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  3. Emotional distress
  4. Pain
  5. Psychological trauma
  6. Ascites (accumulation of fluid in the abdominal cavity)
  7. Asthenia (weakness)
  8. Bone pain
  9. Constipation
  10. Death

1 - 2 years:

  1. Headache (pain in head)
  2. Hypertension (high blood pressure)
  3. Hypertensive crisis
  4. Myalgia (muscle pain)
  5. Pain in extremity
  6. Tonsillitis (inflammation of tonsil)
  7. Febrile neutropenia (fever with reduced white blood cells)
  8. Arthralgia (joint pain)
  9. Blood pressure increased
  10. Constipation

2 - 5 years:

  1. Febrile neutropenia (fever with reduced white blood cells)

5 - 10 years:

  1. Alopecia (absence of hair from areas of the body)
  2. Anxiety
  3. Depression
  4. Hair colour changes
  5. Hair disorder

10+ years:

n/a

not specified:

  1. Arthralgia (joint pain)
  2. Pyrexia (fever)
  3. Pain
  4. Anxiety
  5. Fatigue (feeling of tiredness)
  6. Anaemia (lack of blood)
  7. Pain in extremity
  8. Alopecia (absence of hair from areas of the body)
  9. Constipation
  10. Hypoaesthesia (reduced sense of touch or sensation)

* Approximation only. Some reports may have incomplete information.

Do you take Neulasta and Dexamethasone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.



Related publications that referenced our studies:

Related studies:

How the study uses the data?

The study is based on (applicable) gender, age, pegfilgrastim and dexamethasone (the active ingredients of Neulasta and Dexamethasone, respectively), and Neulasta and Dexamethasone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: